Oracle's $156B AI Buildout: The $100B Cash Flow Gap

The scale of Oracle's AI infrastructure buildout is staggering. The company faces a required capital expenditure of $156 billion to fund its data-center expansion. This massive outlay is intended to meet contracted demand from major clients like OpenAI and Meta. Yet the planned financing falls far short of this need.

Oracle's board-approved plan for 2026 aims to raise $45-50 billion in gross cash proceeds through a mix of equity and debt. This includes a $20 billion at-the-market equity program and a single bond issuance. While aggressive, this raise represents only a fraction of the total capital required for the buildout.

The resulting gap is over $100 billion. This shortfall is the direct driver behind the company's urgent cost-cutting measures. As investment bank TD Cowen noted, the financing challenge stems from the sheer scale of Oracle's commitments. The company is now considering workforce reductions and the sale of assets like Cerner to free up cash flow and alleviate the pressure of securing external funding.

The $8B-10B Cost-Cut Bridge: A Stopgap, Not a Solution

Oracle's board-approved plan for 2026 aims to raise $45-50 billion in gross cash proceeds through a mix of equity and debt. This includes a $20 billion at-the-market equity program and a single bond issuance. While aggressive, this raise represents only a fraction of the total capital required for the buildout.

The resulting gap is over $100 billion. This shortfall is the direct driver behind the company's urgent cost-cutting measures. As investment bank TD Cowen noted, the financing challenge stems from the sheer scale of Oracle's commitments. The company is now considering workforce reductions and the sale of assets like Cerner to free up cash flow and alleviate the pressure of securing external funding.

The proposed workforce reductions and asset sales are a direct response to the capital raise shortfall, not a retreat from the buildout. Oracle is considering cutting 20,000 to 30,000 jobs, a move that TD Cowen estimates would free up $8 billion to $10 billion in annual cash flow. This is a significant liquidity bridge, but it is a stopgap measure to buy time for the company to secure the remaining capital.

The potential sale of the Cerner health unit is another piece of this liquidity puzzle. Oracle acquired the healthcare software company for $28.3 billion in 2022. Selling it would provide a large, one-time cash infusion to help close the $100B+ gap. Yet, this sale is not a strategic pivot away from AI infrastructure; it is a financial maneuver to fund the same $156B capex commitment.

The key point is that these actions do not reduce the underlying capital expenditure need. They are stopgaps to alleviate immediate pressure while the company scrambles for alternative financing. The banking retreat has already driven up borrowing costs and stalled deals, forcing Oracle to explore every option, from customer deposits to BYOC arrangements. The cost cuts and asset sales are part of that scramble, not a sign the buildout is being scaled back.

The $40B RPO Backlog: Demand Flow vs. Execution Risk

The company's $156B capex plan is directly backed by a powerful contracted demand flow. Remaining Performance Obligations (RPO) grew 40% year-over-year last quarter, with cloud RPO surging 56%. This backlog is the primary driver for the massive infrastructure buildout, locking in future revenue and providing near-term visibility. Management expects $4 billion in incremental revenues in fiscal 2027 tied directly to recently signed AI contracts.

Yet this strong demand also creates significant execution risk. The backlog locks Oracle into delivering the promised capacity, which requires flawless timing and cost control. Any delay in the $45B+ financing or in the physical construction of data centers could strain the company's ability to meet client deadlines. The risk is that overcommitment to this backlog, without sufficient liquidity, could lead to cost overruns or forced, dilutive equity sales later.

To fund the buildout while managing this risk, Oracle is splitting the $45B raise roughly evenly between debt and equity. The plan includes a $20 billion at-the-market equity program and a single bond issuance, aiming to maintain an investment-grade balance sheet. This balanced approach is designed to mitigate the downsides of either pure debt (higher leverage) or pure equity (dilution). The key will be executing the phased equity sales and bond offering without spooking the market, as recent share price weakness and rising credit-default swaps show investor skepticism about the near-term returns.